Hypothalamic histamine H1 receptor-AMPK signaling time-dependently mediates olanzapine-induced hyperphagia and weight gain in female rats

Psychoneuroendocrinology

Volumn 42, Issue , 2014, Pages 153-164

  He, Meng ^a   Zhang, Qingsheng ^a   Deng, Chao ^a,b   Wang, Hongqin ^a   Lian, Jiamei ^a   Huang, Xu Feng ^a,b  

^a UNIVERSITY OF WOLLONGONG   (Australia)

^b SCHIZOPHRENIA RESEARCH INSTITUTE   (Australia)

Author keywords

AMP activated protein kinase; Antipsychotics; Food intake; Histamine H1 receptor; Olanzapine; Weight gain

Indexed keywords

2 (3 TRIFLUOROMETHYLPHENYL)HISTAMINE; CORTICOTROPIN RELEASING FACTOR; HISTAMINE H1 RECEPTOR; HISTAMINE H1 RECEPTOR AGONIST; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; MESSENGER RNA; OLANZAPINE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; FEMALE; FOOD INTAKE; GENE EXPRESSION; HISTAMINE H1 RECEPTOR GENE; HYPERPHAGIA; MOLECULAR PATHOLOGY; NONHUMAN; OBESITY; PRIORITY JOURNAL; RAT; RECEPTOR UPREGULATION; SIGNAL TRANSDUCTION; WEIGHT GAIN;

AMP-ACTIVATED PROTEIN KINASE; ANTIPSYCHOTICS; FOOD INTAKE; HISTAMINE H1 RECEPTOR; OLANZAPINE; WEIGHT GAIN;

ADENYLATE KINASE; ANIMALS; ANTIPSYCHOTIC AGENTS; BENZODIAZEPINES; FEMALE; HYPERPHAGIA; PHOSPHORYLATION; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, HISTAMINE H1; SIGNAL TRANSDUCTION; TIME FACTORS; WEIGHT GAIN;

EID: 84895867108     PISSN: 03064530     EISSN: 18733360     Source Type: Journal    
DOI: 10.1016/j.psyneuen.2014.01.018     Document Type: Article

References (55)

1. Allison D.B., Casey D.E. Antipsychotic-induced weight gain: a review of the literature. J. Clin. Psychiatry 2001, 62:22-31.
2. Bond R.A., Ijzerman A.P. Recent developments in constitutive receptor activity and inverse agonism, and their potential for GPCR drug discovery. Trends Pharmacol. Sci. 2006, 27:92-96.
3. Cuerda C., Merchan-Naranjo J., Velasco C., Gutierrez A., Leiva M., de Castro M.J., Parellada M., Giráldez M., Bretón I., Camblor M., García-Peris P., Dulín E., Sanz I., Desco M., Arango C. Influence of resting energy expenditure on weight gain in adolescents taking second-generation antipsychotics. Clin. Nutr. 2011, 30:616-623.
4. Deng C., Lian J., Pai N., Huang X.F. Reducing olanzapine-induced weight gain side effect by using betahistine: a study in the rat model. J. Psychopharmacol. 2012, 26:1271-1279.
5. Deng C., Weston-Green K., Huang X.F. The role of histaminergic H1 and H3 receptors in food intake: a mechanism for atypical antipsychotic-induced weight gain?. Prog. Neuropsychopharmacol. Biol. Psychiatry 2010, 34:1-4.
6. du Bois T.M., Newell K.A., Huang X.F. Perinatal phencyclidine treatment alters neuregulin 1/erbB4 expression and activation in later life. Eur. Neuropsychopharmacol. 2012, 22:356-363.
7. Fadel J., Bubser M., Deutch A.Y. Differential activation of orexin neurons by antipsychotic drugs associated with weight gain. J. Neurosci. 2002, 22:6742-6746.
8. Fei W., Tian D.-R., Tso P., Han J.-S. Diet-induced obese rats exhibit impaired LKB1-AMPK signaling in hypothalamus and adipose tissue. Peptides 2012, 35:23-30.
9. Ferno J., Varela L., Skrede S., Vazquez M.J., Nogueiras R., Dieguez C., Vidal-Puig A., Steen V.M., Lopez M. Olanzapine-induced hyperphagia and weight gain associate with orexigenic hypothalamic neuropeptide signaling without concomitant AMPK phosphorylation. PLoS One 2011, 6.
10. Fisher F.M., Kleiner S., Douris N., Fox E.C., Mepani R.J., Verdeguer F., Wu J., Kharitonenkov A., Flier J.S., Maratos-Flier E., Spiegelman B.M. FGF21 regulates PGC-1alpha and browning of white adipose tissues in adaptive thermogenesis. Genes Dev. 2012, 26:271-281.
11. Fukagawa K., Sakata T., Shiraishi T., Yoshimatsu H., Fujimoto K., Ookuma K., Wada H. Neuronal histamine modulates feeding behavior through H1-receptor in rat hypothalamus. Am. J. Physiol. 1989, 256:R605-R611.
12. Gotoh K., Fukagawa K., Fukagawa T., Noguchi H., Kakuma T., Sakata T., Yoshimatsu H. Glucagon-like peptide-1, corticotropin-releasing hormone, and hypothalamic neuronal histamine interact in the leptin-signaling pathway to regulate feeding behavior. FASEB J. 2005, 19:1131-1133.
13. Han M., Deng C., Burne T.H.J., Newell K.A., Huang X.F. Short- and long-term effects of antipsychotic drug treatment on weight gain and H1 receptor expression. Psychoneuroendocrinology 2008, 33:569-580.
14. He M., Deng C., Huang X.F. The role of hypothalamic H1 receptor antagonism in antipsychotic-induced weight gain. CNS Drugs 2013, 27:423-434.
15. Hong S.T., Bang S., Paik D., Kang J.K., Hwang S., Jeon K., Chun B., Hyun S., Lee Y., Kim J. Histamine and its receptors modulate temperature-preference behaviors in Drosophila. J. Neurosci. 2006, 26:7245-7256.
16. Huang X.F., Han M., Huang X., Zavitsanou K., Deng C. Olanzapine differentially affects 5-HT2Aand2C receptor mRNA expression in the rat brain. Behav. Brain Res. 2006, 171:355-362.
17. Humbert-Claude M., Davenas E., Gbahou F., Vincent L., Arrang J.M. Involvement of histamine receptors in the atypical antipsychotic profile of clozapine: a reassessment in vitro and in vivo. Psychopharmacology (Berl) 2012, 220:225-241.
18. Jorgensen E.A., Knigge U., Watanabe T., Warberg J., Kjaer A. Histaminergic neurons are involved in the orexigenic effect of orexin-A. Neuroendocrinology 2005, 82:70-77.
19. Kim S.F., Huang A.S., Snowman A.M., Teuscher C., Snyder S.H. Antipsychotic drug-induced weight gain mediated by histamine H-1 receptor-linked activation of hypothalamic AMP-kinase. PNAS 2007, 104:3456-3459.
20. Kjaer A., Knigge U., Plotsky P.M., Bach F.W., Warberg J. Histamine H1-receptor and H2-receptor activation stimulates acth and beta-endorphin secretion by increasing corticotropin-releasing hormone in the hypophyseal portal blood. Neuroendocrinology 1992, 56:851-855.
21. Kjaer A., Larsen P.J., Knigge U., Jorgensen H., Warberg J. Neuronal histamine and expression of corticotropin-releasing hormone, vasopressin and oxytocin in the hypothalamus: relative importance of H-1 and H-2 receptors. Eur. J. Endocrinol. 1998, 139:238-243.
22. Kjaer A., Larsen P.J., Knigge U., Moller M., Warberg J. Histamine stimulates c-fos expression in hypothalamic vasopressin-releasing, oxytocin-releasing, and corticotropin-releasing hormone-containing neurons. Endocrinology 1994, 134:482-491.
23. Kroeze W.K., Hufeisen S.J., Popadak B.A., Renock S., Steinberg S.A., Ernsberger P., Jayathilake K., Meltzer H.Y., Roth B.L. H1-histamine receptor affinity predicts short-term weight gain for typical and atypical antipsychotic drugs. Neuropsychopharmacology 2003, 28:519-526.
24. Lage R., Dieguez C., Vidal-Puig A., Lopez M. AMPK: a metabolic gauge regulating whole-body energy homeostasis. Trends Mol. Med. 2008, 14:539-549.
25. Lecklin A., Etu-Seppala P., Stark H., Tuomisto L. Effects of intracerebroventricularly infused histamine and selective H-1, H-2 and H-3 agonists on food and water intake and urine flow in Wistar rats. Brain Res. 1998, 793:279-288.
26. Lopez M., Lage R., Saha A.K., Perez-Tilve D., Vazquez M.J., Varela L., Sangiao-Alvarellos S., Tovar S., Raghay K., Rodriguez-Cuenca S., Deoliveira R.M., Castaneda T., Datta R., Dong J.Z., Culler M., Sleeman M.W., Alvarez C.V., Gallego R., Lelliott C.J., Carling D., Tschop M.H., Dieguez C., Vidal-Puig A. Hypothalamic fatty acid metabolism mediates the orexigenic action of ghrelin. Cell Metab. 2008, 7:389-399.
27. Lundius E.G., Sanchez-Alavez M., Ghochani Y., Klaus J., Tabarean I.V. Histamine influences body temperature by acting at H1 and H3 receptors on distinct populations of preoptic neurons. J Neurosci. 2010, 30:4369-4381.
28. Martin T.L., Alquier T., Asakura K., Furukawa N., Preitner F., Kahn B.B. Diet-induced obesity alters AMP kinase activity in hypothalamus and skeletal muscle. J. Biol. Chem. 2006, 281:18933-18941.
29. Martins P.J., Haas M., Obici S. Central nervous system delivery of the antipsychotic olanzapine induces hepatic insulin resistance. Diabetes 2010, 59:2418-2425.
30. Masaki T., Chiba S., Yasuda T., Noguchi H., Kakuma T., Watanabe T., Sakata T., Yoshimatsu H. Involvement of hypothalamic histamine H-1 receptor in the regulation of feeding rhythm and obesity. Diabetes 2004, 53:2250-2260.
31. Masaki T., Yoshimatsu H. The hypothalamic H1 receptor: a novel therapeutic target for disrupting diurnal feeding rhythm and obesity. Trends Pharmacol. Sci. 2006, 27:279-284.
32. Matsui-Sakata A., Ohtani H., Sawada Y. Receptor occupancy-based analysis of the contributions of various receptors to antipsychotics-induced weight gain and diabetes mellitus. Drug Metab. Pharmacokinet. 2005, 20:368-378.
33. Minokoshi Y., Alquier T., Furukawa N., Kim Y.B., Lee A., Xue B.Z., Mu J., Foufelle F., Ferre P., Birnbaum M.J., Stuck B.J., Kahn B.B. AMP-kinase regulates food intake by responding to hormonal and nutrient signals in the hypothalamus. Nature 2004, 428:569-574.
34. Ookuma K., Sakata T., Fukagawa K., Yoshimatsu H., Kurokawa M., Machidori H., Fujimoto K. Neuronal histamine in the hypothalamus suppresses food intake in rats. Brain Res. 1993, 628:235-242.
35. Ookuma K., Yoshimatsu H., Sakata T., Fujimoto K., Fukagawa F. Hypothalamic sites of neuronal histamine action on food intake by rats. Brain Res. 1989, 490:268-275.
36. Pai N., Deng C., Vella S.-L., Castle D., Huang X.-F. Are there different neural mechanisms responsible for three stages of weight gain development in anti-psychotic therapy: temporally based hypothesis. Asian J. Psychiatry 2012, 5:315-318.
37. Panariello F., Polsinelli G., Borlido C., Monda M., De Luca V. The role of leptin in antipsychotic-induced weight gain: genetic and non-genetic factors. J. Obes. 2012, 2012:572848.
38. Paxinos G., Watson C. The Rat Brain in Stereotaxic Coordinates 2007, Elsevier, Amsterdam. sixth ed.
39. Poyurovsky M., Fuchs C., Pashinian A., Levi A., Weizman R., Weizman A. Reducing antipsychotic-induced weight gain in schizophrenia: a double-blind placebo-controlled study of reboxetine-betahistine combination. Psychopharmacology (Berl) 2013, 226:615-622.
40. Poyurovsky M., Pashinian A., Levi A., Weizman R., Weizman A. The effect of betahistine, a histamine H1 receptor agonist/H3 antagonist, on olanzapine-induced weight gain in first-episode schizophrenia patients. Int. Clin. Psychopharmacol. 2005, 20:101-103.
41. Reagan-Shaw S., Nihal M., Ahmad N. Dose translation from animal to human studies revisited. FASEB J. 2008, 22:659-661.
42. Sakata T., Ookuma K., Fukagawa K., Fujimoto K., Yoshimatsu H., Shiraishi T., Wada H. Blockade of the histamine H1-receptor in the rat ventromedial hypothalamus and feeding elicitation. Brain Res. 1988, 441:403-407.
43. Schmidt R.H., Jokinen J.D., Massey V.L., Falkner K.C., Shi X., Yin X., Zhang X., Beier J.I., Arteel G.E. Olanzapine activates hepatic mammalian target of rapamycin: new mechanistic insight into metabolic dysregulation with atypical antipsychotic drugs. J. Pharmacol. Exp. Ther. 2013, 347:126-135.
44. Schmittgen T.D., Livak K.J. Analyzing real-time PCR data by the comparative C(T) method. Nat. Protoc. 2008, 3:1101-1108.
45. Sejima E., Yamauchi A., Nishioku T., Koga M., Nakagama K., Dohgu S., Futagami K., Kataoka Y. A role for hypothalamic AMP-activated protein kinase in the mediation of hyperphagia and weight gain induced by chronic treatment with olanzapine in female rats. Cell Mol. Neurobiol. 2011, 31:985-989.
46. Skrede S., Martins L., Berge R.K., Steen V.M., Lopez M., Ferno J. Olanzapine depot formulation in rat: a step forward in modelling antipsychotic-induced metabolic adverse effects. Int. J. Neuropsychopharmacol. 2013, 1-14.
47. Stefanidis A., Verty A.N.A., Allen A.M., Owens N.C., Cowley M.A., Oldfield B.J. The role of thermogenesis in antipsychotic drug-induced weight gain. Obesity 2008, 17:16-24.
48. Tringali G., Lisi L., De Simone M.L., Aubry J.M., Preziosi P., Pozzoli G., Navarra P. Effects of olanzapine and quetiapine on corticotropin-releasing hormone release in the rat brain. Prog. Neuropsychopharmacol. Biol. Psychiatry 2009, 33:1017-1021.
49. Umehara H., Mizuguchi H., Mizukawa N., Matsumoto M., Takeda N., Senba E., Fukui H. Innervation of histamine neurons in the caudal part of the arcuate nucleus of hypothalamus and their activation in response to food deprivation under scheduled feeding. Methods Find. Exp. Clin. Pharmacol. 2010, 32:733-736.
50. Viollet B., Horman S., Leclerc J., Lantier L., Foretz M., Billaud M., Giri S., Andreelli F. AMPK inhibition in health and disease. Crit. Rev. Biochem. Mol. Biol. 2010, 45:276-295.
51. Weston-Green K., Huang X.F., Deng C. Olanzapine treatment and metabolic dysfunction: a dose response study in female Sprague Dawley rats. Behav. Brain Res. 2011, 217:337-346.
52. Whittle A.J., Carobbio S., Martins L., Slawik M., Hondares E., Vazquez M.J., Morgan D., Csikasz R.I., Gallego R., Rodriguez-Cuenca S., Dale M., Virtue S., Villarroya F., Cannon B., Rahmouni K., Lopez M., Vidal-Puig A. BMP8B increases brown adipose tissue thermogenesis through both central and peripheral actions. Cell 2012, 149:871-885.
53. Yasuda T., Masaki T., Sakata T., Yoshimatsu H. Hypothalamic neuronal histamine regulates sympathetic nerve activity and expression of uncoupling protein 1 mRNA in brown adipose tissue in rats. Neuroscience 2004, 125:535-540.
54. Zhang Q., He M., Deng C., Wang H., Lian J., Huang X. Brown adipose tissue thermogenesis is time-dependently downregulated by olanzapine in rats. The 31st Annual Scientific Meeting of The Obesity Society 2013, T-715-P.
55. Zhang Q., He M., Deng C., Wang H., Lian J., Huang X. Hypothalamic ghrelin signalling mediates olanzapine-induced hyperphagia and weight gain in female rats. Int. J. Neuropsychopharmacol. 2014, doi: 10.1017/S1461145713001697, In press.